Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550544

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550544

Injectable Drugs Market, By Molecule Type, By Route of Administration, By Therapeutic Area, By Drug Class, By Distribution Channel, By Geography

PUBLISHED:
PAGES: 168 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Global injectable drugs market is estimated to be valued at USD 570.11 Billion in 2024 and is expected to reach USD 946.09 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 570.11 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 7.50% 2031 Value Projection: US$ 946.09 Bn
Figure. Injectable Drugs Market Share (%), By Region 2024
Injectable Drugs Market - IMG1

Injectable drugs refer to medications that are administered directly into the body, mostly through veins, muscles or tissues. These are preferred over other drug delivery methods for various critical care therapies, owing to their ability to deliver medications directly into the bloodstream, ensuring rapid onset of action. Advancements in drug delivery technologies have led to development of novel injectable formulations with improved stability, solubility and bioavailability of active pharmaceutical ingredients. Growing prevalence of chronic diseases, rising focus on biologics and targeted drug therapies, and increasing demand for self-administered injectables can drive the market growth.

Market Dynamics:

Global injectable drugs market growth is driven by rising prevalence of chronic diseases such as cancer, diabetes and autoimmune disorders. According to WHO, chronic diseases are estimated to account for over 60% of global deaths. Rapid adoption of biologics and targeted drug therapies for treatment of cancer and autoimmune diseases can also drive the market growth. However, high costs associated with R&D and manufacturing of injectable products can pose challenges for the market players. Risk of needle-stick injuries while administering injectables can also hamper its adoption. Growing demand for self-administered injectables especially for management of chronic diseases can offer growth opportunities in the near future.

Key features of the study:

This report provides in-depth analysis of the global injectable drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global injectable drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Novartis, Sanofi, GlaxoSmithKline, Gilead Sciences and AbbVie

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drugs market

Detailed Segmentation-

  • By Molecule Type Insights (Revenue, USD Bn, 2019 - 2031)
    • Small Molecule
    • Large Molecule
  • By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
    • Intravenous
    • Intramuscular
    • Subcutaneous
    • Others (Intradermal etc.)
  • By Therapeutic Area Insights (Revenue, USD Bn, 2019 - 2031)
    • Oncology
    • Infectious Diseases
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Endocrinology
    • Neurology
    • Others (Respiratory, Hematology, etc.)
  • By Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
    • Monoclonal Antibodies
    • Peptides and Proteins
    • Small Molecules
    • Immunoglobulins
    • Hormones
    • Others (Vaccines, Biologics, etc.)
  • By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.
    • AstraZeneca Plc
    • Merck & Co., Inc.
    • Viatris + Mylan N.V
    • Cipla Inc.
    • Dr Reddy's Laboratories Ltd.
    • Samsung Biologics
    • Abbott Laboratories
    • Amgen Incorporated
    • Baxter International Incorporated
    • Becton Dickinson and Company
    • Bristol-Myers Squibb Company
    • GlaxoSmithKline Plc
    • Roche Holding Limited
Product Code: CMI5378

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Injectable Drugs Market, By Molecule Type
    • Global Injectable Drugs Market, By Route of Administration
    • Global Injectable Drugs Market, By Therapeutic Area
    • Global Injectable Drugs Market, By Drug Class
    • Global Injectable Drugs Market, By Distribution Channel
    • Global Injectable Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Injectable Drugs Market, By Molecule Type, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Small Molecule
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Large Molecule
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Injectable Drugs Market, By Route of Administration, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Subcutaneous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others (Intradermal etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Injectable Drugs Market, By Therapeutic Area, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Autoimmune Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others (Respiratory, Hematology, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Injectable Drugs Market, By Drug Class, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Monoclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Peptides and Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Small Molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Immunoglobulins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Hormones
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others (Vaccines, Biologics, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Injectable Drugs Market, By Distribution Channel, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Injectable Drugs Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020- 2031, (USD Bn)
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • AstraZeneca Plc
  • Merck & Co., Inc.
  • Viatris + Mylan N.V
  • Cipla Inc.
  • Dr Reddy's Laboratories Ltd.
  • Samsung Biologics
  • Abbott Laboratories
  • Amgen Incorporated
  • Baxter International Incorporated
  • Becton Dickinson and Company
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Roche Holding Limited

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!